Sign up to save your podcasts
Or
Share FDA’s Peter Marks on Approval of Child Vaccines, Boosters, Immunity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA’s Peter Marks on Approval of Child Vaccines, Boosters, Immunity
Director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration, Dr. Peter Marks, joins Dr. Marc Siegel and discusses the Pfizer vaccine for children ages 5 to 11 and the data that shows it is safe and effective, as well as boosters and vaccine timing for durable immunity.
View all episodes
By SiriusXMDirector of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration, Dr. Peter Marks, joins Dr. Marc Siegel and discusses the Pfizer vaccine for children ages 5 to 11 and the data that shows it is safe and effective, as well as boosters and vaccine timing for durable immunity.